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the epidemic PCR-ribotype 001. In 
particular, the identity between the 
2 PCR ribotypes was 100% for the 
HMW proteins and 77% for the LMW 
proteins.
This study provides convincing 
evidence that the S-layer is well con-
served in C. difﬁ  cile PCR-ribotype 
027 strains and has high identity with 
the slpA of the epidemic PCR-ribo-
type 001. Because C. difﬁ  cile PCR-
ribotypes 027 and 001 are the most 
frequently isolated strains from severe 
CDIs across both North America and 
Europe (9,10), the result obtained sug-
gests that the S-layer of these virulent 
strains presents peculiar and common 
characteristics that could be an advan-
tage for these bacteria during the in-
fection process.
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Introduction 
of Japanese 
Encephalitis Virus 
Genotype I, India 
To the Editor: Seasonal out-
breaks of fatal acute encephalitis syn-
drome (AES) occur regularly in sever-
al parts of India. Japanese encephalitis 
virus (JEV) has been the major and 
consistent cause of these outbreaks in 
the Gorakhpur region of Uttar Pradesh 
State, accounting for ≈10%–15% of 
total AES cases annually (1–3). In 
India, vaccinations against Japanese 
encephalitis (JE) are administered in 
areas where the disease is hyperen-
demic, including Gorakhpur, and AES 
cases are regularly investigated to 
clarify the effects of vaccination. Cur-
rently, >2,000 patients with AES are 
admitted each year to Baba Raghav 
Das Medical College, Gorakhpur.
JEV is classiﬁ  ed into 5 genotypes. 
Genotype III (GIII) is widely distrib-
uted in Asian countries, including 
Japan, South Korea, the People’s Re-
public of China, Taiwan, Vietnam, the 
Philippines, India, Nepal, and Sri Lan-
ka (4). However, during the past de-
cade, JEV GI has been introduced into 
South Korea, Thailand, and China and 
has replaced the GIII strains that had 
been circulating in Japan and Vietnam 
during the mid-1990s (5). Until 2007, 
all known JEV strains isolated in India 
belonged to GIII (2–4,6).
The JE-endemic Gorakhpur region 
recorded a sudden increase in AES cas-
es during September–November 2009. 
Clinical specimens collected from 694 
hospitalized patients were examined for 
JEV infection by JEV-speciﬁ  c immuno-
globulin M capture ELISA (7). Clinical 
specimens comprising 115 (16.6%) ce-
rebrospinal ﬂ  uid (CSF) specimens and 
114 (16.4%) serum specimens showed 
recent JE infection among 158 (22.7%) 
of the case-patients.
All CSF specimens were pro-
cessed for JEV genome detection by 
diagnostic reverse transcription–PCR 
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(RT-PCR), which ampliﬁ   ed the nu-
cleocapsid-premembrane genes (7). 
Additionally, envelope (E) gene–spe-
ciﬁ   c primers designed from Indian 
JEV isolate GP78 (GenBank acces-
sion no. AF075723) were used for E 
gene ampliﬁ  cation.
The diagnostic RT-PCR de-
tected JEV in 66 (9.5%) of 694 
CSF specimens (GenBank acces-
sion nos. HM156543–HM156569, 
HM156573–HM156611). Among 
them, 27 sequences differed from 
the remaining 39, with only 86.2%–
88.7% nt identity. The group of 27 
sequences showed 99.2%–100% nt 
identity with each other and a high of 
95.0% nt identity with Japanese GI 
swine JEV isolate (AB241119). The 
39 sequences showed 94.2%–100.0% 
nt identity with each other and with 
other Indian GIII JEV strains. These 
ﬁ   ndings indicate that both GI and 
GIII JEV strains circulate in the 
Gorakhpur region.
The E gene sequence was am-
pliﬁ   ed from 4/66 JEV-positive 
CSF samples (GenBank acces-
sion nos. HM156570–HM156572, 
HM156612). A comparison of E gene 
nucleotide sequences those of other 
JEV isolates from the region showed 
that 1 E gene sequence belonged to 
GIII and the other 3 to GI (Figure). 
The 3 GI E gene sequences were most 
similar (98.6%) with Japanese isolate 
95–167/1995/swine (AY377579), fol-
lowed by 98.5% similarity with Kore-
an isolate K96A07/1996 (FJ938219). 
The single GIII E gene sequence 
showed 95.6%–99.8% nt identity 
with other Indian GIII isolates with 
the highest similarity (99.8% nt) with 
the 014178 (EF623987) JEV isolate 
from the 2001 Uttar Pradesh outbreak. 
Analysis of the E gene sequence am-
pliﬁ  ed from 2 JEV isolates, obtained 
by injecting 29 CSF samples, posi-
tive by RT-PCR, into baby hamster 
kidney cells, showed 100.0% nt iden-
tity with sequences directly ampliﬁ  ed 
from respective CSF specimens (3). 
Phylogenetic analysis of these E gene 
sequences, along with other 55 Gen-
Bank sequences, conﬁ  rmed that 3 se-
quences belonged to JEV GI, and 1 
belonged to GIII (Figure).
The ﬁ  rst JE outbreak in the Gora-
khpur region was documented during 
1978. Since then, JE epidemics have 
occurred regularly (8). This study 
demonstrated simultaneous detec-
tion and isolation of GI and GIII JEV 
strains from AES case-patients. Docu-
mented clinical symptoms among pa-
tients infected with the 2 strains were 
indistinguishable.
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Figure. Phylogenetic tree constructed by using a 1,381-nt Japanese encephalitis virus 
(JEV) envelope sequence directly ampliﬁ  ed from cerebrospinal ﬂ  uid specimens collected 
during the acute phase of illness from hospitalized acute encephalitis syndrome patients, 
India, September–November 2009. Multiple sequence alignment and phylogenetic 
analysis were conducted by using ClustalW software (www.ebi.ac.uk/Tools/clustalw2/
index.html) and MEGA version 4 (www.megasoftware.net). The phylogenetic tree was 
constructed by the neighbor-joining method and the maximum composite likelihood model. 
The robustness of branching patterns was tested by 1,000 bootstrap pseudo replications. 
Sequences obtained in this study are indicated in boldface. Genotypes are indicated on 
the right. Viruses were identiﬁ  ed by using the nomenclature of accession number–strain 
name–country of origin/year of isolation. Bootstrap values are indicated above the major 
branch. The tree was rooted within the Japanese encephalitis serogoup by using Murray 
Valley encephalitis virus (AF161266) and 55 JEV sequences from GenBank were used in 
the analysis. Scale bar indicates nucleotide substitutions per site. LETTERS
GI JEV isolates from India share 
close genetic relationship with GI 
strains from Japan and Korea. In In-
dia, JEV neutralizing antibodies have 
been detected in 179 (34.8%) of 514 
birds, including pond herons and cat-
tle egrets, indicating a possible role in 
virus maintenance (9). Large perenni-
al lakes, swamps, and rice ﬁ  elds pro-
vide a wintering and staging ground 
for several migratory waterfowl; such 
areas also favor breeding and survival 
of mosquitoes (10). Considering these 
conditions, GI JEV may have been in-
troduced into India through migratory 
birds, as it has in other Asian countries 
(5). However, the exact mode of in-
troduction of GI JEV into India is not 
known, and further studies are needed 
to determine the role of migratory 
birds in JE transmission.
This study suggests the recent in-
troduction of JEV GI strain in India. 
Simultaneous detection of GI and GIII 
strains indicates their co-circulation 
and association with human infections 
in Gorakhpur region. Because the live 
attenuated JE vaccine used in India is 
derived from GIII strain SA14–14–2, 
the efﬁ  cacy of the vaccine to protect 
against GI JEV must be carefully eval-
uated. Thus, the genetic and antigenic 
variation among JEV strains circulat-
ing in India should be monitored to 
determine effects on JE epidemiology 
and ongoing vaccination efforts. Addi-
tionally, the expansion of GI JEV into 
other parts of India should be continu-
ously tracked.
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Dengue Virus 
Serotype 3 
Subtype III, 
Zhejiang Province, 
China
To the Editor: Beginning in July 
2009, physicians in the city of Yiwu, 
Zhejiang Province, People’s Republic 
of China, noted an outbreak of illness 
characterized by rash, headache, sub-
jective fever, itching, anorexia, and 
arthritis. We present the results of the 
investigation of this outbreak, which 
was caused by dengue virus (DENV) 
serotype 3 (DENV-3) subtype III.
DENV-3 subtype III has been 
continuously circulating in the Indian 
subcontinent since the 1960s. The vi-
rus was ﬁ  rst isolated from East Africa 
in 1985 in Mozambique and subse-
quently in Kenya (1991) and Somalia 
(1993) (1,2). Although dengue has 
occurred frequently in southern Chi-
na, including Guangdong, Guangxi, 
Hainan, Fujian, and Zhejiang Prov-
inces and in Taiwan (3–6), to our 
knowledge, DENV-3 subtype III has 
not been reported in China.
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